Literature DB >> 8759670

Abdominal ultrasound in the assessment of extent and activity of Crohn's disease: clinical significance and implication of bowel wall thickening.

G Maconi1, F Parente, S Bollani, B Cesana, G Bianchi Porro.   

Abstract

AIMS: The aim of this study was to evaluate the relevance of ultrasound (US) in assessing disease extent and activity in a series of patients with quiescent or active Crohn's disease (CD). In particular, the study was aimed at evaluating whether US may be useful in distinguishing between active disease and bowel wall thickening (BWT) due to fibrosis. PATIENTS AND METHODS: A series of consecutive patients with ileal, ileo-colonic, or colonic CD previously studied with x-ray and/or endoscopy, underwent abdominal US. The following parameters were also determined in these patients: CD activity index (CDAI), erythrocyte sedimentation rate, C reactive protein, length of disease, previous surgical resection, and number of recurrences. The relationship between BWT and the aforesaid parameters was assessed by means of univariate and multiple regression analysis.
RESULTS: Overall sensitivity and specificity of US for the assessment of anatomical distribution of CD were 89% and 94%, respectively, and there was also a significant correlation between the extent of ileal disease measured by US and that determined by small bowel x-ray. By univariate analysis, statistically significant correlations were found between BWT, CDAI, and biological indices of inflammation (erythrocyte sedimentation rate and C reactive protein), although all the correlation coefficients were low with values not exceeding 0.40, and among these, backward multiple regression analysis identified only CDAI, along with ileo-colonic localization, as the subset of predictive variables of bowel wall thickness. However, both predictions were rather weak and accounted for only 20% of the variability of the BWT. In addition, a significant relationship was found between disease US extent and clinical or biochemical disease activity. However, in a subgroup of patients characterized by quiescent disease and high BWT, CD was complicated by higher prevalence of strictures, as detected by radiological and endoscopic examinations, and more frequent surgical outcome than others.
CONCLUSIONS: Abdominal US is an accurate method for determining the abdominal distribution of CD and appears to be accurate in detecting and evaluating the disease length of ileal lesions. In contrast, despite a weak but significant correlation between BWT and clinical and biochemical parameters, the usefulness of US as an index of disease activity seems to be fairly limited. However, a high BWT in quiescent patients suggests the presence of fibrosis, which is poorly responsive to steroid treatment.

Entities:  

Mesh:

Year:  1996        PMID: 8759670

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  25 in total

Review 1.  Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis.

Authors:  Eduardo Garcia Vilela; Henrique Osvaldo da Gama Torres; Fabiana Paiva Martins; Maria de Lourdes de Abreu Ferrari; Marcella Menezes Andrade; Aloísio Sales da Cunha
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Ultrasonographic detection of toxic megacolon in inflammatory bowel diseases.

Authors:  Giovanni Maconi; Gianluca M Sampietro; Sandro Ardizzone; Massimo Cristaldi; Piergiorgio Danelli; Luca Carsana; Gabriele Bianchi Porro
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

3.  Contrast-enhanced ultrasonography (CEUS) vs. MRI of the small bowel in the evaluation of Crohn's disease activity.

Authors:  R Malagò; M D'Onofrio; W Mantovani; G D'Alpaos; G Foti; A Pezzato; G Caliari; D Cusumano; L Benini; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2012-01-21       Impact factor: 3.469

Review 4.  Pediatric Small Bowel Crohn Disease: Correlation of US and MR Enterography.

Authors:  Jonathan R Dillman; Ethan A Smith; Ramon J Sanchez; Michael A DiPietro; Vera DeMatos-Maillard; Peter J Strouse; Kassa Darge
Journal:  Radiographics       Date:  2015-04-03       Impact factor: 5.333

Review 5.  Imaging of the small bowel in Crohn's disease: a review of old and new techniques.

Authors:  Simone Saibeni; Emanuele Rondonotti; Andrea Iozzelli; Luisa Spina; Gian-Eugenio Tontini; Flaminia Cavallaro; Camilla Ciscato; Roberto de Franchis; Francesco Sardanelli; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

6.  Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease.

Authors:  José María Paredes; Tomás Ripollés; Xavier Cortés; María Jesús Martínez; María Barrachina; Fernando Gómez; Eduardo Moreno-Osset
Journal:  Dig Dis Sci       Date:  2009-03-07       Impact factor: 3.199

7.  Quantitative Inflammation Assessment for Crohn Disease Using Ultrasensitive Ultrasound Microvessel Imaging: A Pilot Study.

Authors:  Ping Gong; Pengfei Song; Amy B Kolbe; Shannon P Sheedy; Chengwu Huang; Wenwu Ling; Yue Yu; Chenyun Zhou; U Wai Lok; Shanshan Tang; David H Bruining; John M Knudsen; Shigao Chen
Journal:  J Ultrasound Med       Date:  2020-04-16       Impact factor: 2.153

8.  Ultrasonographic findings in Crohn's disease.

Authors:  Gabriella Carnevale Maffè; Laura Brunetti; Pietro Formagnana; Gino Roberto Corazza
Journal:  J Ultrasound       Date:  2014-05-24

9.  Power Doppler sonography to predict the risk of surgical recurrence of Crohn's disease.

Authors:  Davide Giuseppe Ribaldone; Teresa Cammarota; Andrea Resegotti; Antonino Sarno; Daniela Robotti; Paola Debani; Giovanni Bonenti; Francesca Bresso; Rinaldo Pellicano; Alessandro Adriani; Carlo Sguazzini; Stefania Reggiani; Marco Astegiano
Journal:  J Ultrasound       Date:  2014-06-12

10.  Factors affecting splanchnic haemodynamics in Crohn's disease: a prospective controlled study using Doppler ultrasound.

Authors:  G Maconi; F Parente; S Bollani; V Imbesi; S Ardizzone; A Russo; G Bianchi Porro
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.